salicylic acid has been researched along with Kawasaki Disease in 4 studies
Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).
Excerpt | Relevance | Reference |
---|---|---|
" Duration of fever, SGPT, serum salicylate, plasma thromboxane B2 (TxB2) and 6-keto-prostaglandin F1 alpha (PGF1 alpha) levels were compared before enrollment and on days 4, 7 and 14 of treatment." | 5.07 | Salicylate treatment in Kawasaki disease: high dose or low dose? ( Akagi, T; Inoue, O; Kato, H; Sato, N, 1991) |
"We described the pharmacokinetics of acetylsalicylic acid and salicylic acid in 5 children with prior Kawasaki disease receiving buffered aspirin tablets or intravenous aspirin DL-lysine." | 3.68 | Disposition of single-dose intravenous and oral aspirin in children. ( Ito, S; Oka, R; Tsuchida, A; Yoshioka, H, 1991) |
"8 years (range 8 months to 8 years), who had Kawasaki disease treated with acetylsalicylic acid (ASA) 30 to 180 mg/kg." | 3.67 | Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease. ( Koren, G; MacLeod, SM, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chua, PK | 1 |
Yanagihara, R | 1 |
Melish, ME | 1 |
Nerurkar, VR | 1 |
Koren, G | 1 |
MacLeod, SM | 1 |
Ito, S | 1 |
Oka, R | 1 |
Tsuchida, A | 1 |
Yoshioka, H | 1 |
Akagi, T | 1 |
Kato, H | 1 |
Inoue, O | 1 |
Sato, N | 1 |
1 trial available for salicylic acid and Kawasaki Disease
Article | Year |
---|---|
Salicylate treatment in Kawasaki disease: high dose or low dose?
Topics: 6-Ketoprostaglandin F1 alpha; Alanine Transaminase; Child, Preschool; Dose-Response Relationship, Dr | 1991 |
3 other studies available for salicylic acid and Kawasaki Disease
Article | Year |
---|---|
Modulation of adhesion molecules and monocyte chemoattractant protein by tumor necrosis factor-alpha and salicylic acid in primary human coronary artery endothelial cells.
Topics: Cell Adhesion Molecules; Cells, Cultured; Coronary Vessels; Endothelial Cells; Humans; Monocyte Chem | 2003 |
Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Mu | 1984 |
Disposition of single-dose intravenous and oral aspirin in children.
Topics: Absorption; Administration, Oral; Aspirin; Biological Availability; Buffers; Child, Preschool; Drug | 1991 |